Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV005040760 | SCV005680136 | uncertain significance | Colorectal cancer | 2024-01-02 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004730713 | SCV005339487 | uncertain significance | DLC1-related disorder | 2024-06-03 | no assertion criteria provided | clinical testing | The DLC1 c.112G>A variant is predicted to result in the amino acid substitution p.Asp38Asn. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0029% of alleles in individuals of Latino descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |